nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenoxybenzamine—SLC22A3—Lamivudine—acquired immunodeficiency syndrome	0.124	0.15	CbGbCtD
Phenoxybenzamine—SLC22A1—Indinavir—acquired immunodeficiency syndrome	0.0976	0.118	CbGbCtD
Phenoxybenzamine—SLC22A1—Nelfinavir—acquired immunodeficiency syndrome	0.0948	0.115	CbGbCtD
Phenoxybenzamine—SLC22A2—Zidovudine—acquired immunodeficiency syndrome	0.0946	0.114	CbGbCtD
Phenoxybenzamine—SLC22A1—Saquinavir—acquired immunodeficiency syndrome	0.0857	0.104	CbGbCtD
Phenoxybenzamine—SLC22A2—Lamivudine—acquired immunodeficiency syndrome	0.0732	0.0885	CbGbCtD
Phenoxybenzamine—SLC22A1—Lamivudine—acquired immunodeficiency syndrome	0.0636	0.0769	CbGbCtD
Phenoxybenzamine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0244	0.0295	CbGbCtD
Phenoxybenzamine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.023	0.0278	CbGbCtD
Phenoxybenzamine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.023	0.0278	CbGbCtD
Phenoxybenzamine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0208	0.0251	CbGbCtD
Phenoxybenzamine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0208	0.0251	CbGbCtD
Phenoxybenzamine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0179	0.0217	CbGbCtD
Phenoxybenzamine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.0174	0.021	CbGbCtD
Phenoxybenzamine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0157	0.019	CbGbCtD
Phenoxybenzamine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0157	0.019	CbGbCtD
Phenoxybenzamine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0151	0.0183	CbGbCtD
Phenoxybenzamine—CALM2—semen—acquired immunodeficiency syndrome	0.00593	0.0694	CbGeAlD
Phenoxybenzamine—CALM1—semen—acquired immunodeficiency syndrome	0.00591	0.0691	CbGeAlD
Phenoxybenzamine—CALM2—nerve—acquired immunodeficiency syndrome	0.00286	0.0335	CbGeAlD
Phenoxybenzamine—CALM1—nerve—acquired immunodeficiency syndrome	0.00285	0.0333	CbGeAlD
Phenoxybenzamine—CALM2—endothelium—acquired immunodeficiency syndrome	0.00243	0.0285	CbGeAlD
Phenoxybenzamine—CALM1—endothelium—acquired immunodeficiency syndrome	0.00242	0.0284	CbGeAlD
Phenoxybenzamine—CALM2—blood plasma—acquired immunodeficiency syndrome	0.00216	0.0253	CbGeAlD
Phenoxybenzamine—CALM1—blood plasma—acquired immunodeficiency syndrome	0.00215	0.0252	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00178	0.06	CcSEcCtD
Phenoxybenzamine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.00154	0.018	CbGeAlD
Phenoxybenzamine—CALM3—retina—acquired immunodeficiency syndrome	0.00151	0.0176	CbGeAlD
Phenoxybenzamine—SLC22A2—digestive system—acquired immunodeficiency syndrome	0.00145	0.017	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00139	0.0468	CcSEcCtD
Phenoxybenzamine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00121	0.0142	CbGeAlD
Phenoxybenzamine—CALM2—retina—acquired immunodeficiency syndrome	0.00118	0.0139	CbGeAlD
Phenoxybenzamine—CALM1—retina—acquired immunodeficiency syndrome	0.00118	0.0138	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00113	0.0382	CcSEcCtD
Phenoxybenzamine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.00107	0.0126	CbGeAlD
Phenoxybenzamine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.00105	0.0123	CbGeAlD
Phenoxybenzamine—Orthostatic hypotension—Ritonavir—acquired immunodeficiency syndrome	0.00105	0.0354	CcSEcCtD
Phenoxybenzamine—CALM2—skin of body—acquired immunodeficiency syndrome	0.00104	0.0122	CbGeAlD
Phenoxybenzamine—CALM1—skin of body—acquired immunodeficiency syndrome	0.00103	0.0121	CbGeAlD
Phenoxybenzamine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.00103	0.0121	CbGeAlD
Phenoxybenzamine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.00101	0.0118	CbGeAlD
Phenoxybenzamine—CALM3—blood—acquired immunodeficiency syndrome	0.00101	0.0118	CbGeAlD
Phenoxybenzamine—Drowsiness—Efavirenz—acquired immunodeficiency syndrome	0.000999	0.0337	CcSEcCtD
Phenoxybenzamine—CALM3—bone marrow—acquired immunodeficiency syndrome	0.000976	0.0114	CbGeAlD
Phenoxybenzamine—SLC22A1—blood—acquired immunodeficiency syndrome	0.000976	0.0114	CbGeAlD
Phenoxybenzamine—CALM3—spinal cord—acquired immunodeficiency syndrome	0.000972	0.0114	CbGeAlD
Phenoxybenzamine—CALM3—vagina—acquired immunodeficiency syndrome	0.000935	0.0109	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000915	0.0309	CcSEcCtD
Phenoxybenzamine—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.000909	0.0307	CcSEcCtD
Phenoxybenzamine—SLC22A1—vagina—acquired immunodeficiency syndrome	0.000904	0.0106	CbGeAlD
Phenoxybenzamine—CALM3—lung—acquired immunodeficiency syndrome	0.000884	0.0103	CbGeAlD
Phenoxybenzamine—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000873	0.0295	CcSEcCtD
Phenoxybenzamine—SLC22A3—vagina—acquired immunodeficiency syndrome	0.000864	0.0101	CbGeAlD
Phenoxybenzamine—CALM2—lymphoid tissue—acquired immunodeficiency syndrome	0.000842	0.00985	CbGeAlD
Phenoxybenzamine—CALM1—lymphoid tissue—acquired immunodeficiency syndrome	0.000838	0.0098	CbGeAlD
Phenoxybenzamine—CALM2—digestive system—acquired immunodeficiency syndrome	0.000831	0.00973	CbGeAlD
Phenoxybenzamine—CALM1—digestive system—acquired immunodeficiency syndrome	0.000827	0.00968	CbGeAlD
Phenoxybenzamine—ADRA1B—brain—acquired immunodeficiency syndrome	0.00082	0.0096	CbGeAlD
Phenoxybenzamine—SLC22A3—lung—acquired immunodeficiency syndrome	0.000817	0.00957	CbGeAlD
Phenoxybenzamine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000803	0.00939	CbGeAlD
Phenoxybenzamine—SLC22A1—nervous system—acquired immunodeficiency syndrome	0.000792	0.00927	CbGeAlD
Phenoxybenzamine—CALM2—blood—acquired immunodeficiency syndrome	0.000792	0.00927	CbGeAlD
Phenoxybenzamine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000789	0.00924	CbGeAlD
Phenoxybenzamine—CALM1—blood—acquired immunodeficiency syndrome	0.000788	0.00923	CbGeAlD
Phenoxybenzamine—Somnolence—Nevirapine—acquired immunodeficiency syndrome	0.000768	0.0259	CcSEcCtD
Phenoxybenzamine—CALM2—bone marrow—acquired immunodeficiency syndrome	0.000766	0.00897	CbGeAlD
Phenoxybenzamine—CALM2—spinal cord—acquired immunodeficiency syndrome	0.000763	0.00893	CbGeAlD
Phenoxybenzamine—CALM1—bone marrow—acquired immunodeficiency syndrome	0.000763	0.00893	CbGeAlD
Phenoxybenzamine—SLC22A1—central nervous system—acquired immunodeficiency syndrome	0.000763	0.00892	CbGeAlD
Phenoxybenzamine—CALM1—spinal cord—acquired immunodeficiency syndrome	0.00076	0.00889	CbGeAlD
Phenoxybenzamine—SLC22A3—nervous system—acquired immunodeficiency syndrome	0.000757	0.00886	CbGeAlD
Phenoxybenzamine—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000757	0.0255	CcSEcCtD
Phenoxybenzamine—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000745	0.0251	CcSEcCtD
Phenoxybenzamine—Somnolence—Nelfinavir—acquired immunodeficiency syndrome	0.000744	0.0251	CcSEcCtD
Phenoxybenzamine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000743	0.00869	CbGeAlD
Phenoxybenzamine—Somnolence—Stavudine—acquired immunodeficiency syndrome	0.000742	0.025	CcSEcCtD
Phenoxybenzamine—CALM2—vagina—acquired immunodeficiency syndrome	0.000734	0.00859	CbGeAlD
Phenoxybenzamine—CALM1—vagina—acquired immunodeficiency syndrome	0.000731	0.00855	CbGeAlD
Phenoxybenzamine—SLC22A3—central nervous system—acquired immunodeficiency syndrome	0.000729	0.00853	CbGeAlD
Phenoxybenzamine—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00072	0.0243	CcSEcCtD
Phenoxybenzamine—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000709	0.0239	CcSEcCtD
Phenoxybenzamine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000708	0.00828	CbGeAlD
Phenoxybenzamine—CALM2—lung—acquired immunodeficiency syndrome	0.000694	0.00813	CbGeAlD
Phenoxybenzamine—CALM1—lung—acquired immunodeficiency syndrome	0.000691	0.00809	CbGeAlD
Phenoxybenzamine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00069	0.0233	CcSEcCtD
Phenoxybenzamine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000682	0.00798	CbGeAlD
Phenoxybenzamine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000656	0.00768	CbGeAlD
Phenoxybenzamine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000645	0.0218	CcSEcCtD
Phenoxybenzamine—CALM2—nervous system—acquired immunodeficiency syndrome	0.000643	0.00752	CbGeAlD
Phenoxybenzamine—CALM1—nervous system—acquired immunodeficiency syndrome	0.00064	0.00749	CbGeAlD
Phenoxybenzamine—CALM3—brain—acquired immunodeficiency syndrome	0.000626	0.00732	CbGeAlD
Phenoxybenzamine—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000625	0.0211	CcSEcCtD
Phenoxybenzamine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000622	0.021	CcSEcCtD
Phenoxybenzamine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000621	0.00726	CbGeAlD
Phenoxybenzamine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00062	0.0209	CcSEcCtD
Phenoxybenzamine—CALM2—central nervous system—acquired immunodeficiency syndrome	0.000619	0.00724	CbGeAlD
Phenoxybenzamine—CALM1—central nervous system—acquired immunodeficiency syndrome	0.000616	0.00721	CbGeAlD
Phenoxybenzamine—SLC22A1—brain—acquired immunodeficiency syndrome	0.000605	0.00709	CbGeAlD
Phenoxybenzamine—CALM3—lymph node—acquired immunodeficiency syndrome	0.000605	0.00708	CbGeAlD
Phenoxybenzamine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000603	0.00706	CbGeAlD
Phenoxybenzamine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000601	0.0203	CcSEcCtD
Phenoxybenzamine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.0006	0.0202	CcSEcCtD
Phenoxybenzamine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000599	0.0202	CcSEcCtD
Phenoxybenzamine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000595	0.0201	CcSEcCtD
Phenoxybenzamine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00059	0.0199	CcSEcCtD
Phenoxybenzamine—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000582	0.0196	CcSEcCtD
Phenoxybenzamine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000581	0.00679	CbGeAlD
Phenoxybenzamine—SLC22A3—brain—acquired immunodeficiency syndrome	0.000579	0.00677	CbGeAlD
Phenoxybenzamine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000575	0.00673	CbGeAlD
Phenoxybenzamine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000567	0.0191	CcSEcCtD
Phenoxybenzamine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000565	0.00661	CbGeAlD
Phenoxybenzamine—SLC22A3—lymph node—acquired immunodeficiency syndrome	0.000559	0.00654	CbGeAlD
Phenoxybenzamine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000553	0.00647	CbGeAlD
Phenoxybenzamine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00055	0.0186	CcSEcCtD
Phenoxybenzamine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00055	0.0185	CcSEcCtD
Phenoxybenzamine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000544	0.00637	CbGeAlD
Phenoxybenzamine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000542	0.0183	CcSEcCtD
Phenoxybenzamine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000526	0.0177	CcSEcCtD
Phenoxybenzamine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000524	0.00613	CbGeAlD
Phenoxybenzamine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00052	0.0176	CcSEcCtD
Phenoxybenzamine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000501	0.0169	CcSEcCtD
Phenoxybenzamine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000495	0.00579	CbGeAlD
Phenoxybenzamine—CALM2—brain—acquired immunodeficiency syndrome	0.000491	0.00575	CbGeAlD
Phenoxybenzamine—CALM1—brain—acquired immunodeficiency syndrome	0.000489	0.00573	CbGeAlD
Phenoxybenzamine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000486	0.0164	CcSEcCtD
Phenoxybenzamine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000484	0.0163	CcSEcCtD
Phenoxybenzamine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000483	0.0163	CcSEcCtD
Phenoxybenzamine—CALM2—lymph node—acquired immunodeficiency syndrome	0.000475	0.00556	CbGeAlD
Phenoxybenzamine—CALM1—lymph node—acquired immunodeficiency syndrome	0.000473	0.00553	CbGeAlD
Phenoxybenzamine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000468	0.0158	CcSEcCtD
Phenoxybenzamine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000467	0.00546	CbGeAlD
Phenoxybenzamine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000461	0.00539	CbGeAlD
Phenoxybenzamine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.00046	0.0155	CcSEcCtD
Phenoxybenzamine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000459	0.00537	CbGeAlD
Phenoxybenzamine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000457	0.0154	CcSEcCtD
Phenoxybenzamine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000446	0.0151	CcSEcCtD
Phenoxybenzamine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000445	0.0052	CbGeAlD
Phenoxybenzamine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000441	0.00517	CbGeAlD
Phenoxybenzamine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000439	0.00514	CbGeAlD
Phenoxybenzamine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000438	0.0148	CcSEcCtD
Phenoxybenzamine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000424	0.00497	CbGeAlD
Phenoxybenzamine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000405	0.0137	CcSEcCtD
Phenoxybenzamine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000389	0.0131	CcSEcCtD
Phenoxybenzamine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000372	0.0125	CcSEcCtD
Phenoxybenzamine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000361	0.00422	CbGeAlD
Phenoxybenzamine—ADRA2A—brain—acquired immunodeficiency syndrome	0.00035	0.0041	CbGeAlD
Phenoxybenzamine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000347	0.00407	CbGeAlD
Phenoxybenzamine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000339	0.00396	CbGeAlD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.01e-05	0.000516	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.01e-05	0.000516	CbGpPWpGaD
Phenoxybenzamine—CALM2—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	3e-05	0.000515	CbGpPWpGaD
Phenoxybenzamine—CALM1—Downstream signal transduction—IL6—acquired immunodeficiency syndrome	3e-05	0.000515	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.99e-05	0.000513	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	2.99e-05	0.000512	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by FGFR—IL6—acquired immunodeficiency syndrome	2.99e-05	0.000512	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.98e-05	0.000511	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CCR2—acquired immunodeficiency syndrome	2.97e-05	0.00051	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	2.97e-05	0.00051	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by ERBB2—IL6—acquired immunodeficiency syndrome	2.97e-05	0.00051	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.96e-05	0.000508	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.96e-05	0.000508	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	2.96e-05	0.000508	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	2.96e-05	0.000508	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.96e-05	0.000507	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 signaling—IL6—acquired immunodeficiency syndrome	2.96e-05	0.000507	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	2.92e-05	0.0005	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.9e-05	0.000498	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.89e-05	0.000496	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.89e-05	0.000496	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CCR2—acquired immunodeficiency syndrome	2.88e-05	0.000493	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CCR2—acquired immunodeficiency syndrome	2.88e-05	0.000493	CbGpPWpGaD
Phenoxybenzamine—CALM3—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.88e-05	0.000493	CbGpPWpGaD
Phenoxybenzamine—CALM3—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.88e-05	0.000493	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.88e-05	0.000493	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.87e-05	0.000492	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—ALB—acquired immunodeficiency syndrome	2.85e-05	0.00049	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.85e-05	0.000489	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Hemostasis—IL2—acquired immunodeficiency syndrome	2.85e-05	0.000489	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.83e-05	0.000485	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.83e-05	0.000485	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.83e-05	0.000485	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.82e-05	0.000484	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.81e-05	0.000482	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.81e-05	0.000482	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.79e-05	0.000478	CbGpPWpGaD
Phenoxybenzamine—CALM2—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000477	CbGpPWpGaD
Phenoxybenzamine—CALM1—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000477	CbGpPWpGaD
Phenoxybenzamine—CALM2—DAP12 interactions—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000477	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000477	CbGpPWpGaD
Phenoxybenzamine—CALM1—Fc epsilon receptor (FCERI) signaling—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000477	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by FGFR in disease—IL6—acquired immunodeficiency syndrome	2.78e-05	0.000477	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.78e-05	0.000476	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.77e-05	0.000475	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.76e-05	0.000473	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by EGFR—IL6—acquired immunodeficiency syndrome	2.76e-05	0.000473	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.75e-05	0.000471	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.74e-05	0.00047	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.73e-05	0.000469	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by EGFR in Cancer—IL6—acquired immunodeficiency syndrome	2.73e-05	0.000469	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.72e-05	0.000467	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.72e-05	0.000467	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by PDGF—IL6—acquired immunodeficiency syndrome	2.72e-05	0.000467	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.71e-05	0.000464	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFNA1—acquired immunodeficiency syndrome	2.68e-05	0.000459	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.61e-05	0.000448	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.61e-05	0.000448	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—ALB—acquired immunodeficiency syndrome	2.6e-05	0.000447	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD79A—acquired immunodeficiency syndrome	2.6e-05	0.000446	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.59e-05	0.000445	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFNA1—acquired immunodeficiency syndrome	2.59e-05	0.000444	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFNA1—acquired immunodeficiency syndrome	2.59e-05	0.000444	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CXCR4—acquired immunodeficiency syndrome	2.58e-05	0.000443	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.58e-05	0.000442	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.58e-05	0.000442	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.55e-05	0.000438	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.55e-05	0.000438	CbGpPWpGaD
Phenoxybenzamine—CALM3—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.55e-05	0.000437	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.53e-05	0.000434	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—ALB—acquired immunodeficiency syndrome	2.52e-05	0.000432	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—ALB—acquired immunodeficiency syndrome	2.52e-05	0.000432	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD79A—acquired immunodeficiency syndrome	2.51e-05	0.000431	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD79A—acquired immunodeficiency syndrome	2.51e-05	0.000431	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.51e-05	0.000431	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.51e-05	0.00043	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CXCR4—acquired immunodeficiency syndrome	2.5e-05	0.000428	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CXCR4—acquired immunodeficiency syndrome	2.5e-05	0.000428	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.47e-05	0.000424	CbGpPWpGaD
Phenoxybenzamine—CALM2—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.46e-05	0.000423	CbGpPWpGaD
Phenoxybenzamine—CALM1—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.46e-05	0.000423	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.44e-05	0.000418	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.44e-05	0.000418	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.4e-05	0.000412	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.4e-05	0.000412	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.4e-05	0.000412	CbGpPWpGaD
Phenoxybenzamine—SLC22A3—Metabolism—ALB—acquired immunodeficiency syndrome	2.34e-05	0.000401	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.33e-05	0.0004	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.33e-05	0.000399	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	2.31e-05	0.000397	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.3e-05	0.000394	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.29e-05	0.000393	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.27e-05	0.000389	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.25e-05	0.000386	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.25e-05	0.000386	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.22e-05	0.000381	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.22e-05	0.000381	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.2e-05	0.000377	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.17e-05	0.000372	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.14e-05	0.000366	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.13e-05	0.000366	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.13e-05	0.000366	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.13e-05	0.000365	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD40LG—acquired immunodeficiency syndrome	2.12e-05	0.000363	CbGpPWpGaD
Phenoxybenzamine—CALM3—Hemostasis—IL2—acquired immunodeficiency syndrome	2.11e-05	0.000362	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.11e-05	0.000361	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.1e-05	0.00036	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD8A—acquired immunodeficiency syndrome	2.1e-05	0.000359	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CSF2—acquired immunodeficiency syndrome	2.1e-05	0.000359	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—CD4—acquired immunodeficiency syndrome	2.07e-05	0.000354	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.06e-05	0.000353	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.06e-05	0.000353	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD40LG—acquired immunodeficiency syndrome	2.05e-05	0.000352	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD40LG—acquired immunodeficiency syndrome	2.05e-05	0.000352	CbGpPWpGaD
Phenoxybenzamine—CALM2—Hemostasis—IL2—acquired immunodeficiency syndrome	2.04e-05	0.00035	CbGpPWpGaD
Phenoxybenzamine—CALM1—Hemostasis—IL2—acquired immunodeficiency syndrome	2.04e-05	0.00035	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CSF2—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CSF2—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD8A—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD8A—acquired immunodeficiency syndrome	2.03e-05	0.000348	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—HLA-B—acquired immunodeficiency syndrome	2.02e-05	0.000346	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—CD4—acquired immunodeficiency syndrome	2e-05	0.000343	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—CD4—acquired immunodeficiency syndrome	2e-05	0.000343	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.99e-05	0.000341	CbGpPWpGaD
Phenoxybenzamine—CALM3—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.98e-05	0.00034	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.98e-05	0.00034	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.98e-05	0.00034	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.98e-05	0.00034	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.96e-05	0.000336	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—HLA-B—acquired immunodeficiency syndrome	1.95e-05	0.000334	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—HLA-B—acquired immunodeficiency syndrome	1.95e-05	0.000334	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.94e-05	0.000333	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.93e-05	0.000331	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.93e-05	0.000331	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.92e-05	0.00033	CbGpPWpGaD
Phenoxybenzamine—CALM1—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.92e-05	0.000329	CbGpPWpGaD
Phenoxybenzamine—CALM2—Adaptive Immune System—CD4—acquired immunodeficiency syndrome	1.92e-05	0.000329	CbGpPWpGaD
Phenoxybenzamine—ADRB2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.9e-05	0.000326	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000325	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by NGF—IL6—acquired immunodeficiency syndrome	1.9e-05	0.000325	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.86e-05	0.000319	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.86e-05	0.000319	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.86e-05	0.000318	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.83e-05	0.000314	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.83e-05	0.000313	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.81e-05	0.00031	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.81e-05	0.00031	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.8e-05	0.000309	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.000309	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.79e-05	0.000307	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.77e-05	0.000304	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CCR5—acquired immunodeficiency syndrome	1.77e-05	0.000304	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.77e-05	0.000303	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.75e-05	0.0003	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.75e-05	0.0003	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.75e-05	0.0003	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.75e-05	0.0003	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.75e-05	0.0003	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.73e-05	0.000296	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000294	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CCR5—acquired immunodeficiency syndrome	1.71e-05	0.000294	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.67e-05	0.000287	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.65e-05	0.000282	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.64e-05	0.00028	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.62e-05	0.000278	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.61e-05	0.000276	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.6e-05	0.000274	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.57e-05	0.00027	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.51e-05	0.000259	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000255	CbGpPWpGaD
Phenoxybenzamine—SLC22A2—Metabolism—ALB—acquired immunodeficiency syndrome	1.46e-05	0.000251	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000251	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000251	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.43e-05	0.000245	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	1.42e-05	0.000244	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.38e-05	0.000236	CbGpPWpGaD
Phenoxybenzamine—SLC22A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.37e-05	0.000234	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.000233	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.35e-05	0.000232	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000228	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.33e-05	0.000228	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000228	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000225	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.31e-05	0.000225	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IFNG—acquired immunodeficiency syndrome	1.25e-05	0.000214	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.24e-05	0.000213	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000208	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IFNG—acquired immunodeficiency syndrome	1.21e-05	0.000207	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IFNG—acquired immunodeficiency syndrome	1.21e-05	0.000207	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—CD4—acquired immunodeficiency syndrome	1.2e-05	0.000206	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.000206	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.000206	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.17e-05	0.000201	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—CD4—acquired immunodeficiency syndrome	1.16e-05	0.0002	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—CD4—acquired immunodeficiency syndrome	1.16e-05	0.0002	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	1.16e-05	0.000198	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000196	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000195	CbGpPWpGaD
Phenoxybenzamine—CALM3—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.12e-05	0.000192	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—CD4—acquired immunodeficiency syndrome	1.11e-05	0.000191	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL2—acquired immunodeficiency syndrome	1.11e-05	0.00019	CbGpPWpGaD
Phenoxybenzamine—CALM1—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.08e-05	0.000185	CbGpPWpGaD
Phenoxybenzamine—CALM2—Innate Immune System—IL6—acquired immunodeficiency syndrome	1.08e-05	0.000185	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—CD4—acquired immunodeficiency syndrome	1.07e-05	0.000184	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—CD4—acquired immunodeficiency syndrome	1.07e-05	0.000184	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000184	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL2—acquired immunodeficiency syndrome	1.07e-05	0.000184	CbGpPWpGaD
Phenoxybenzamine—CALM3—Metabolism—ALB—acquired immunodeficiency syndrome	1.06e-05	0.000181	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000177	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.03e-05	0.000176	CbGpPWpGaD
Phenoxybenzamine—CALM1—Metabolism—ALB—acquired immunodeficiency syndrome	1.02e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—CALM2—Metabolism—ALB—acquired immunodeficiency syndrome	1.02e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000175	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.02e-05	0.000174	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.66e-06	0.000166	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.61e-06	0.000165	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.51e-06	0.000163	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.46e-06	0.000162	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.45e-06	0.000145	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.4e-06	0.000144	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.85e-06	0.000135	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.81e-06	0.000134	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.16e-06	0.000123	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.12e-06	0.000122	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.93e-06	0.000119	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.93e-06	0.000119	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.89e-06	0.000118	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.89e-06	0.000118	CbGpPWpGaD
Phenoxybenzamine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.73e-06	0.000115	CbGpPWpGaD
Phenoxybenzamine—CALM3—Immune System—IL6—acquired immunodeficiency syndrome	6.51e-06	0.000112	CbGpPWpGaD
Phenoxybenzamine—CALM1—Immune System—IL6—acquired immunodeficiency syndrome	6.3e-06	0.000108	CbGpPWpGaD
Phenoxybenzamine—CALM2—Immune System—IL6—acquired immunodeficiency syndrome	6.3e-06	0.000108	CbGpPWpGaD
Phenoxybenzamine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.08e-06	0.000104	CbGpPWpGaD
Phenoxybenzamine—CALM3—Disease—IL6—acquired immunodeficiency syndrome	6.01e-06	0.000103	CbGpPWpGaD
Phenoxybenzamine—ADRB2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6e-06	0.000103	CbGpPWpGaD
Phenoxybenzamine—CALM2—Disease—IL6—acquired immunodeficiency syndrome	5.81e-06	9.97e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Disease—IL6—acquired immunodeficiency syndrome	5.81e-06	9.97e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.68e-06	9.74e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.59e-06	9.59e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.96e-06	8.51e-05	CbGpPWpGaD
Phenoxybenzamine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.93e-06	8.46e-05	CbGpPWpGaD
Phenoxybenzamine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.61e-06	7.91e-05	CbGpPWpGaD
Phenoxybenzamine—CALM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.21e-06	7.22e-05	CbGpPWpGaD
Phenoxybenzamine—CALM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.07e-06	6.98e-05	CbGpPWpGaD
Phenoxybenzamine—CALM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.07e-06	6.98e-05	CbGpPWpGaD
